| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.42B | $4.01B | $3.51B |
| YoY Revenue Growth % | +10.4% | +14.2% | — |
| Gross Profit | $711.2M | $572.7M | — |
| Gross Margin % | 16.1% | 14.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $282.4M | $207.4M | $80.1M |
| Operating Margin % | 6.4% | 5.2% | 2.3% |
| Net Income (GAAP) | $193.0M | $126.3M | $43.6M |
| EBITDA (Normalized) | $393.1M | $316.5M | $206.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $468.9M | $456.3M | $183.7M |
| Capital Expenditures (CapEx) | $138.3M | $136.4M | $157.9M |
| Free Cash Flow (FCF) | $330.6M | $319.9M | $25.8M |
| FCF Margin % | 7.5% | 8.0% | 0.7% |
| Return on Invested Capital (ROIC %) | 13.8% | 13.9% | 2.5% |
| Cash & Short-Term Equivalents | $529.2M | $578.3M | — |
| Total Debt (Short + Long Term) | $963.2M | $737.9M | $985.4M |
| Total Stockholders' Equity | $1.18B | $1.02B | $2.02B |